DMRA
Damora Therapeutics, Inc. - Ordinary Shares (DMRA)
$80
About Damora Therapeutics, Inc. - Ordinary Shares (DMRA)
Damora Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Waltham, MA.
Details
Daily high
$32.17
Daily low
$30.29
Price at open
$30.74
52 Week High
$38.33
52 Week Low
$2.45
Market cap
1.9B
Dividend yield
-
Volume
485,659
Avg. volume
389,930
P/E ratio
-.25
Damora Therapeutics, Inc. - Ordinary Shares News
Details
Daily high
$32.17
Daily low
$30.29
Price at open
$30.74
52 Week High
$38.33
52 Week Low
$2.45
Market cap
1.9B
Dividend yield
-
Volume
485,659
Avg. volume
389,930
P/E ratio
-.25